Inventor · disambiguated record
John Desjarlais
Also filed as: DESJARLAIS JOHN · DESJARLAIS JOHN R · DESJARLAIS JOHN RUDOLF · DESJARLAIS JOHN RUDOLPH
176 granted patents·162 pending applications·4,585 citations·filing 2001–2025
99Inventor score
Top patents by PatentIndex Score
338 records- 0199US9605084B2Heterodimeric proteinsXENCOR INC·Filed 2014·Granted Mar 28, 2017·74 cites·16 claims
- 0299US8802820B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2007·Granted Aug 12, 2014·83 cites·4 claims
- 0399US8367805B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2008·Granted Feb 5, 2013·210 cites·3 claims
- 0499US8088376B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2011·Granted Jan 3, 2012·191 cites·1 claims
- 0599US8039592B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2007·Granted Oct 18, 2011·86 cites·19 claims
- 0699US7662925B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2006·Granted Feb 16, 2010·349 cites·15 claims
- 0799US7317091B2Optimized Fc variantsXENCOR INC·Filed 2004·Granted Jan 8, 2008·872 cites·1 claims
- 0898US10793632B2Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptorsXENCOR INC·Filed 2017·Granted Oct 6, 2020·22 cites·5 claims
- 0998US10584176B2Fc variants with increased affinity for FcγRIIcXENCOR INC·Filed 2018·Granted Mar 10, 2020·21 cites·10 claims
- 1098US10550185B2Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragmentsXENCOR INC·Filed 2017·Granted Feb 4, 2020·29 cites·13 claims
- 1198US10501543B2IL15/IL15Rα heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2017·Granted Dec 10, 2019·13 cites·6 claims
- 1298US10428155B2Trispecific antibodiesXENCOR INC·Filed 2015·Granted Oct 1, 2019·39 cites·5 claims
- 1398US10336818B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2014·Granted Jul 2, 2019·47 cites·5 claims
- 1498US10259887B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2016·Granted Apr 16, 2019·25 cites·25 claims
- 1598US10227410B2Heterodimeric antibodies that bind CD3 and PSMAXENCOR INC·Filed 2016·Granted Mar 12, 2019·36 cites·27 claims
- 1698US9856327B2Heterodimeric antibodies to CD3 X CD123XENCOR INC·Filed 2016·Granted Jan 2, 2018·72 cites·5 claims
- 1798US9803023B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2015·Granted Oct 31, 2017·62 cites·9 claims
- 1898US9701759B2Heterodimeric proteinsXENCOR INC·Filed 2014·Granted Jul 11, 2017·48 cites·8 claims
- 1998US9650446B2Heterodimeric proteinsXENCOR INC·Filed 2014·Granted May 16, 2017·44 cites·9 claims
- 2098US9051373B2Optimized Fc variantsXENCOR INC·Filed 2013·Granted Jun 9, 2015·40 cites·4 claims
- 2198US8937158B2Fc variants with increased affinity for FcγRIIcLAZAR GREGORY ALAN·Filed 2007·Granted Jan 20, 2015·56 cites·8 claims
- 2298US8883973B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2010·Granted Nov 11, 2014·57 cites·20 claims
- 2398US8735545B2Fc variants having increased affinity for fcyrllcLAZAR GREGORY ALAN·Filed 2007·Granted May 27, 2014·59 cites·9 claims
- 2498US8394925B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2011·Granted Mar 12, 2013·63 cites·4 claims
- 2598US8388955B2Fc variantsLAZAR GREGORY ALAN·Filed 2007·Granted Mar 5, 2013·104 cites·4 claims
- 2698US8383109B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2012·Granted Feb 26, 2013·40 cites·4 claims
- 2798US8188231B2Optimized FC variantsLAZAR GREGORY ALAN·Filed 2005·Granted May 29, 2012·188 cites·10 claims
- 2898US8124731B2Optimized Fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2007·Granted Feb 28, 2012·55 cites·4 claims
- 2998US8093359B2Optimized Fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2007·Granted Jan 10, 2012·58 cites·19 claims
- 3098US8063187B2Methods and compositions for inhibiting CD32B expressing cellsCHU SEUNG YUP·Filed 2008·Granted Nov 22, 2011·130 cites·2 claims
- 3198US7657380B2Methods of generating variant antibodies with increased host string contentXENCOR INC·Filed 2004·Granted Feb 2, 2010·169 cites·47 claims
- 3297US12492253B1Anti-human C5 antibodiesXENCOR INC·Filed 2025·Granted Dec 9, 2025·1 cites·1 claims
- 3397US11591401B2Anti-CD28 compositionsXENCOR INC·Filed 2021·Granted Feb 28, 2023·19 cites·5 claims
- 3497US11225528B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2019·Granted Jan 18, 2022·11 cites·13 claims
- 3597US10787518B2Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2017·Granted Sep 29, 2020·15 cites·19 claims
- 3697US10526417B2Heterodimeric antibodies that bind CD3 and CD38XENCOR INC·Filed 2015·Granted Jan 7, 2020·27 cites·15 claims
- 3797US10184000B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2016·Granted Jan 22, 2019·20 cites·38 claims
- 3897US8753629B2Optimized Fc variantsLAZAR GREGORY ALAN·Filed 2013·Granted Jun 17, 2014·29 cites·26 claims
- 3997US8338574B2FC variants with altered binding to FCRNCHAMBERLAIN AARON KEITH·Filed 2010·Granted Dec 25, 2012·32 cites·5 claims
- 4097US8324351B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2010·Granted Dec 4, 2012·30 cites·5 claims
- 4197US8093357B2Optimized Fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2006·Granted Jan 10, 2012·51 cites·3 claims
- 4296US11919958B2Anti-CD28 compositionsXENCOR INC·Filed 2021·Granted Mar 5, 2024·9 cites·16 claims
- 4396US11358999B2IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2019·Granted Jun 14, 2022·12 cites·2 claims
- 4496US10738133B2Heterodimeric proteinsXENCOR INC·Filed 2017·Granted Aug 11, 2020·9 cites·7 claims
- 4596US9353187B2Optimized FC variants and methods for their generationXENCOR INC·Filed 2013·Granted May 31, 2016·21 cites·9 claims
- 4696US9040041B2Modified FC moleculesDESJARLAIS JOHN R·Filed 2010·Granted May 26, 2015·35 cites·3 claims
- 4796US8858937B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2013·Granted Oct 14, 2014·20 cites·9 claims
- 4896US8802823B2Optimized Fc variantsXENCOR INC·Filed 2013·Granted Aug 12, 2014·24 cites·18 claims
- 4996US8551485B2Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cellsBERNETT MATTHEW J·Filed 2009·Granted Oct 8, 2013·45 cites·27 claims
- 5096US8524867B2Optimized antibodies that target CD19BERNETT MATTHEW J·Filed 2007·Granted Sep 3, 2013·56 cites·32 claims
Showing the top 50 of 338 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Desjarlais files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →